ALXN - Alexion Pharmaceuticals Inc. (ALXN) CEO Ludwig Hantson on Q2 2020 Results - Earnings Call Transcript
Alexion Pharmaceuticals, Inc. (ALXN)
Q2 2020 Results Conference Call
July 30, 2020 08:00 AM ET
Company Participants
Christopher Stevo - Head of Investor Relations
Ludwig Hantson - Chief Executive Officer
Aradhana Sarin - Chief Financial Officer
John Orloff - Global Head of R&D
Brian Goff - Chief Commercial and Global Operations Officer
Conference Call Participants
Josh Schimmer - Evercore ISI
Cory Kasimov - JPMorgan
Geoffrey Porges - SVB Leerink
Christopher Raymond - Piper Sandler
Philip Nadeau - Cowen & Company
Geoff Meacham - Bank of America
Presentation
Operator
Ladies and gentlemen, thank you for standing